Forever Clinic in the media
Foreign visitors can assess their skin condition through AI-powered diagnostics and receive personalized consultations and treatments in one seamless experience. Forever Clinic is gaining attention as a key destination for experiential K-beauty medical tourism, connecting skin analysis, customized treatments, and beauty shopping.
Skin texture deterioration, pigmentation, and loss of elasticity may occur simultaneously due to factors such as UV exposure, aging, and stress. The DEORODUAL Laser combines two different laser technologies, allowing treatment to be tailored to each patient’s skin condition and treatment goals. However, accurate skin assessment and an individualized treatment plan are more important than the choice of device itself. Proper post-treatment care, including sun protection and moisturization, is also essential. [Dr. Chanjong Lee, Medical Director of Forever Clinic Myeongdong]
Myeongdong is re-emerging as a major beauty district, driven by the increase in foreign tourists and the global popularity of K-beauty. Amid this trend, Forever Clinic Myeongdong is welcoming both domestic and international clients with treatments centered on skin boosters, lifting, and anti-aging care. The clinic also plans to operate multilingual consultation and aftercare systems for visitors from China, Japan, Southeast Asia, and other regions. Forever Clinic said it aims to provide reliable medical services to global clients visiting Myeongdong.
Facial sagging and reduced skin elasticity that appear with age are considered closely linked to the decline of collagen in the dermal layer. While conventional PCL and PLLA microparticle-based formulations have been used to stimulate collagen production, concerns have remained over potential side effects such as nodules and granulomas. GOURI is a liquid-form PCL product developed without microparticles, characterized by its high diffusion capacity and ability to spread evenly across the face. Dr. Donghee Kim of Forever Clinic Myeongdong Global said, “GOURI is a practical option that may help improve skin texture, elasticity, and facial contours without the burden of sleep anesthesia.”
Dr. Lee Chan-jong, chief representative of Forever Clinic Myeongdong, announced the introduction of 'Bolix', a facial procedure auxiliary device designed to alleviate tooth sensitivity and discomfort that can occur during Ulthera lifting procedures. Bolix, a Class 1 disposable auxiliary device approved by the Ministry of Food and Drug Safety (MFDS), covers the teeth to reduce sensitivity and prevents the skin from being pushed into the oral cavity, thereby establishing a stable treatment environment. Dr. Lee emphasized that satisfaction with aesthetic medical procedures is organically linked not only to the equipment's performance but also to the comfort and safety experienced by the patient. He noted that meticulous changes, such as utilizing auxiliary devices, can enhance convenience for medical staff and lead to a more positive procedure experience for patients.
Forever Clinic announced that a research paper co-authored by Dr. Chanjong Lee of Forever Clinic has been officially published in the Journal of Cosmetic Dermatology (JCD), an international SCIE-indexed academic journal. The title of the paper is “Liquid-Form Polycaprolactone Injection Enhances Dermal Thickness and Collagen Production in UVB-Induced Photoaging Skin.”
Dexlevo participated in 'AMWC Asia 2026' in Taipei, unveiling GOURI's clinical data and treatment algorithms in preparation for the official Taiwan market launch. Drawing keen interest from local clinicians and buyers across Asia, the company plans to expand throughout Asia with Taiwan as its regional foothold.
![[GOURI Symposium] Dexlevo Medical Director Lee Chan-jong M.D. — New Anti-aging with Liquid PCL](https://cdn.sanity.io/images/ecoamz42/production/56da1d6e312deb5f60c7211ad491fd314f66e64d-1200x800.png?w=600&h=400&auto=format)
Ahead of the 'THE GOURI: Begin in Korea' symposium on May 19, 2026, Dexlevo Medical Director Dr. Lee Chan-jong introduced the mechanism and clinical potential of liquid PCL. The official Korean debut of GOURI, the world's first liquid-type PCL pioneering collagen biostimulation, is anticipated.
At the 2025 Korean Society for Aesthetic & Laser Medicine (DAEMIRE), Dexlevo's liquid PCL biostimulator 'GOURI' drew significant attention. As the world's first fully liquid PCL product, it achieved zero vascular occlusion adverse events over four years, establishing itself as a next-generation anti-aging solution.
